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This study aimed to investigate the effect of three different doses of estradiol-17β on
ovulation and subsequent luteal development and function in llamas. Twenty-three llamas
were examined daily by transrectal ultrasonography until the detection of an ovulatory
follicle (≥8mm). Thereafter, animals were divided into five groups: Control (n = 3; treated
with 1.6ml of saline solution), GnRH group (n = 6, treated with an intravenous injection
of 8.4 µg Buserelin), and estradiol groups that received 0.6mg (E1, n = 4), 1mg (E2,
n = 4), or 1.6mg (E3, n = 6) of estradiol-17β intravenously. Detection of ovulation
was based on ultrasonographic visualization of disappearance of the largest follicle
and subsequent presence of a newly formed corpus luteum (CL) and progesterone
concentration exceeding 1 ng ml−1. Daily blood samples were collected to determine
plasma progesterone concentration. Ovulation rate was 0% for control and E1 groups,
25% for E2 group, and 100% for GnRH and E3 groups. Differences in the mean
CL diameter between GnRH and E3 groups were not statistically significant. Plasma
progesterone concentration was similar between groups during the different days in
ovulated animals. However, the day that the plasma progesterone concentration was
above 1 ng ml−1 and the day that the highest plasma progesterone concentration was
achieved differed among E3 and GnRH groups, occurring later in females treated with
estradiol. In conclusion, an injection of estradiol-17β is capable of inducing ovulation in
llamas and the response depends on the dose used. Most of the animals required the
highest tested dose (1.6mg) to induce the ovulatory process. Although the CL diameter
in females induced to ovulate with estradiol was similar to that in llamas induced to
ovulate with a GnRH analog, the rise in plasma progesterone concentration above 1 ng
ml−1 and the peak progesterone concentration were attained 1 day later in the estradiol
treated females.
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INTRODUCTION
Unlike other species such as sheep and cattle, which ovulate spontaneously as part of their estrous
cycle, female camelids are induced ovulators requiring an external stimulus in the presence of a
follicle with a diameter≥ 7mm to elicit the ovulatory process (1, 2). The luteinizing hormone (LH)
concentration increases by 20min after copulation, peaks within 2–3 h, remains high during 5 h,
and reaches basal concentration by 12 h post-mating (3). An ovulation-inducing factor identified
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as beta nerve growth factor (4, 5) is present in the seminal plasma
of males, which induces the LH secretion and ovulation around
30 h post-mating (6). Besides, the administration of exogenous
hormones that elicit LH release such as gonadotrophin-releasing
hormone (GnRH) or hormones with LH activity such as human
chorionic gonadotrophin (hCG) induces ovulation within an
interval of∼29 h [GnRH: (7)] or 26 h [hCG: (1)].
In spontaneously ovulating species, increasing plasma
concentration of estradiol-17β, in the absence of plasma
progesterone concentration from a corpus luteum (CL), induces
the preovulatory surge of LH and, consequently, ovulation
(8, 9). Moreover, treatment of heifers with estradiol-17β, without
exogenous progesterone or progestogen, is followed by a surge
release of LH (10, 11).
In llamas, the LH secretion and the ovulatory response
depend on follicular size at the time of mating. Females with
follicles ≥7mm in diameter ovulate while those with smaller
ovarian follicles (<6mm) release less LH and do not ovulate
in response to copulation suggesting that this pattern could
be due to a reduced estrogen priming of the hypothalamus–
pituitary axis (2). Plasma estradiol-17β concentration follows
a wavelike pattern with basal concentration recorded, when
small follicles are present in the ovaries (12). Although the
increase in plasma estrogen concentrations does not elicit the LH
preovulatory peak in llamas, it has been suggested that estradiol
modulates the LH secretion by the pituitary in response to the
intramuscular injection of purified ovulation-inducing factor in
this species (13).
All these information show some evidence that estradiol
modulates LH secretion in camelids; however, to our knowledge
there are no reports evaluating the effect of exogenous
administration of estrogens on the ovulatory process in these
species. Thus, this study aimed to investigate the effect of three
different doses of estradiol-17β on ovulation and subsequent
luteal development and function in llamas. The hypothesis was
that estradiol-17β is capable of triggering the ovulatory process
in llamas and that the response depends on the dose used.
MATERIALS AND METHODS
Field studies were performed in compliance with animal welfare
regulations set by the Faculty of Veterinary Sciences, UNCPBA,
where activities were conducted. Animals belong to the Faculty
of Veterinary Sciences, UNCPBA, and facilities are located in
Tandil, Argentina, at 37◦S, 60◦W. Twenty-three nonpregnant,
non-lactating female llamas, ranging between 5 and 12 years
of age and with an average body weight of 100 ± 15 kg,
were included in the study. All animals were clinically and
reproductively healthy with a mean body condition score of 3
(body condition score from 1 = thin to 5 = obese) (14). Llamas
were kept in pens isolated from males and fed pasture hay and
water ad libitum.
Experimental Design
Female llamas were examined daily by transrectal
ultrasonography (Mindray, DP 6600 Vet, with 5.0/7.5 variable
traducer probe) to assess ovarian status. When a growing follicle
with a diameter ≥8mm, considered ovulatory in this species (2),
was observed, animals were randomly assigned to one of five
treatments: control group (1.6ml saline solution, im; n = 3);
GnRH group (8.4 µg acetate of Buserelin, Receptal R©, Intervet,
Argentina, iv; n = 6) and E1, E2, and E3 groups that received
0.6 (n = 4), 1 (n = 4), or 1.6mg (n = 6), respectively, of an
intramuscular injection of estradiol-17β (17β-estradiol, Rio de
Janeiro, Argentina) into the hind leg. Detection of ovulation was
based on ultrasonographic visualization of disappearance of the
largest follicle and subsequent presence of a newly formed CL
and progesterone concentration exceeding 1 ng ml−1.
Thereafter, ultrasonographic examination was performed
daily for 12 days to measure the CL diameter, which was
estimated by averaging two measurements of the CL diameter at
right angles to each other.
Blood samples were collected daily from the day that a
growing follicle ≥8mm was detected (Day 0) and during 12
days in ovulating animals. Blood samples were collected by
jugular venipuncture in tubes with heparin (Heparin Sodium,
SOBRIUS R©, Fada Pharma, Buenos Aires, Argentina) and
centrifuged immediately after collection. Plasma was stored at
−20◦C until hormone assays were performed.
Hormone Determinations
Progesterone was measured using a RIA kit (IM 1188, Beckman
Coulter, Immunotech, Czech Republic) previously validated for
use with llama blood plasma (15). The intra-assay coefficient of
variation was below 5% for concentrations between 0.1 and 40 ng
ml−1. The inter-assay coefficients of variation for three quality-
control samples were 2.9% (0.5 ngml−1), 2.2% (2.0 ngml−1), and
5.8% (10 ng ml−1). The sensitivity of the assay was 0.10 ng ml−1.
Statistical Analysis
Follicle diameters at treatment and at Day 2 were compared
among groups by one-way ANOVA followed by Tukey’s test.
Normal distribution of the variables was tested in all cases
using the Shapiro–Wilk test. For non-normally distributed
variables (first day that a CL was detected, day of maximum CL
diameter, first day plasma progesterone concentration was above
1 ng ml−1, and day that plasma progesterone concentration
returned to values below 1 ng ml−1) the Mann–Whitney
test was used to compare GnRH and E3 groups. For the
remaining characteristics (maximum CL diameter, maximum
progesterone concentration and day of maximum progesterone
concentration), a Student t-test was applied.
The diameter of the CL and plasma progesterone
concentration on the different days and between GnRH and E3
groups were analyzed by repeated measures one-way ANOVA or
one-way ANOVA, respectively, followed by Tukey’s test.
The percentage of animals that ovulated after the different
treatments was compared using Fisher’s exact test.
All statistical analyses were conducted using the Infostat
Professional 2017 software package. Data are presented as mean
± S.E.M. Differences were considered to be significant when
P < 0.05, and a tendency was considered when P < 0.1.
Frontiers in Veterinary Science | www.frontiersin.org 2 October 2020 | Volume 7 | Article 576204
Bianchi et al. Estradiol-17β Induces Ovulation in Llamas
RESULTS
Mean diameter of the largest follicle at the time of treatment was
similar among groups (P= 0.39). Ovulation rate differed between
groups (P= 0.0001). All females treated with 1.6mg of estradiol-
17β (E3 group) ovulated after treatment as all animals injected
with Buserelin and only one llama treated with 1mg of estradiol-
17β (E2 group). Ovulation, assessed by the disappearance of
the largest follicle, was observed 48 h post injection (Day 2) in
all llamas that ovulated in response to the different treatments.
Mean diameter of the largest follicle on Day 2 differed among
groups (P = 0.0001) (Table 1).
A CL was first detected after treatment between Days 4 and
5 in GnRH and E3 groups and on Day 4 in the only llama that
ovulated in the E2 group. Maximum CL diameter (P = 0.73) and
the day on which maximal CL diameter was observed (P = 0.70)
were not different among groups (Table 2).
Mean CL diameter was similar between both groups during
the experimental period (P= 0.90). An effect of day was observed
in the GnRH and E3 groups (P < 0.01). Mean CL diameter in the
GnRH group was smaller on Days 11 and 12 than on Days 6, 7,
8, and 9, and mean CL diameter in the E3 group was smaller on
Day 12 than on Days 7, 8, and 9 (Figure 1).
The first day that the plasma progesterone concentration was
above 1 ng ml−1 tended to be different between GnRH and E3
groups, occurring earlier in the first group (P= 0.07). The highest
plasma progesterone concentration did not differ between both
groups (P = 0.88). However, the day that the highest plasma
progesterone concentration was achieved differed and occurred
between Days 6 and 8 in the GnRH group and between Days
7 and 10 in the E3 group (P = 0.015). The highest plasma
progesterone concentration in the llama that ovulated in the
E2 group was recorded on Day 8 post treatment. The day that
basal plasma progesterone concentration (below 1 ng ml−1) was
observed tended to be different between both groups (P = 0.09)
and was earlier in the GnRH group (Table 2).
Plasma progesterone concentration was similar between
groups during the different days (P = 0.68). An effect of day was
observed in both groups (P < 0.0001), and the highest plasma
progesterone concentration was reached on Days 7, 8, and 9 post
treatment (Figure 2).
DISCUSSION
To our knowledge, this is the first report demonstrating that
an injection of estradiol-17β is effective to induce ovulation in
llamas being the response dependent of the dose. Previously, the
administration of estradiol-17βwas used in an attempt to control
ovarian follicular development in alpacas. D’Occhio et al. (32)
have reported that doses of 0.5 or 2mg of estradiol-17β induce
follicular regression and a new wave emergence regardless of
the stage of follicular development without reporting ovulations.
In a later study, using a dose of 1mg of estradiol-17β, the
author has observed that the diameter of the largest follicle
remained >6mm during all the study, indicating that ovulation
did not occur (16). The disclosure with the later study could
be related to the dose used. In the present study, an effect of
the dose of estradiol-17β was demonstrated, observing ovulation
in 100% of the animals when the highest dose (1.6mg) was
tested. Similarly, a positive correlation between the dose of
estradiol and the magnitude of the LH surge was reported
in other species such as cows (17, 18) and ewes (19, 20).
Although llamas are induced ovulators requiring copulation and
semen deposition to trigger the ovulatory process (21), a close
relationship has been observed between follicular size, plasma
concentration of estradiol-17β, and LH secretion. Females with
small follicles (<6mm) secrete lower concentrations of estradiol-
17β (12, 22) and respond to mating with less LH release (2).
A low percentage of llamas (23) and camels (24) may ovulate
spontaneously. In non-mated dromedary camels, it has been
TABLE 2 | Effect of administration of GnRH and 1.6mg of estradiol-17β (E3
group) on luteal development in llamas (mean ± SEM).
GnRH E3
First day CL detected (day) 4.2 ± 0.31a 4.5 ± 0.22a
Maximum CL diameter (mm) 14.8 ± 1.14a 14.3 ± 0.85a
Day maximum CL diameter
(day)
7.8 ± 0.31a 8.2 ± 0.31a
First day progesterone
concentration > 1 ng ml−1
(day)
4.5 ± 0.22a 5.2 ± 0.20b
Maximum progesterone
concentration (ng ml−1 )
7.1 ± 1.29a 6.8 ± 1.73a
Day maximum progesterone
concentration (day)
7.0 ± 0.37a 8.8 ± 0.49c
Day progesterone
concentration < 1 ng ml−1
(day)
10.0 ± 0.52a 11.4 ± 0.40d
Values with different superscripts within a row are significantly different (a vs. c P = 0.015)
or show a tendency to be different (a vs. b P = 0.07 and a vs. d P = 0.09).
TABLE 1 | Effect of the different treatments on ovulation in llamas (mean ± SEM).
Control GnRH E1 E2 E3
Mean follicular diameter (mm) on day 0 8.2 ± 0.62a 9.7 ± 0.81a 9.5 ± 0.47a 9.6 ± 0.36a 10.0 ± 0.31a
Ovulation rate after treatment (%) 0 (0/3)a 100 (6/6)b 0 (0/4)a 25 (1/4)a 100 (6/6)b
Mean follicular diameter (mm) on Day 2 9.7 ± 0.68x 3.0 ± 0.42y 11.4 ± 1.44x 8.1 ± 2.02x 2.8 ± 0.43y
Values with different superscripts within a row are significantly different.
a vs. b = Proportions with different superscripts are different (P = 0.0001).
x vs. y = differences in mean follicular diameter on Day 2 between groups (P = 0.0001).
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FIGURE 1 | Mean CL diameter (mm) from the first day that CL was detected until Day 12 post-treatment. Gray line: animals treated with Buserelin, analog of GnRH
(n = 6), black line: animals treated with a dose of 1.6mg of estradiol-17β (n = 6), and dotted line represents the only llama that ovulated in response to a dose of
1.0mg of estradiol-17β.
FIGURE 2 | Mean plasma progesterone concentration (ng ml−1 ) from the day of treatment (Day 0) until Day 12 post-treatment. Gray line: animals treated with
Buserelin, analog of GnRH (n = 6), black line: animals treated with a dose of 1.6mg of estradiol-17β (n = 6), and dotted line represents the only llama that ovulated in
response to a dose of 1.0mg of estradiol-17β.
suggested that endogenous estradiol could induce GnRH release
and subsequently stimulate preovulatory LH surge in a low
percentage of female in specific occasions such as lactation or
after a progesterone phase (24). Results hereby presented allow
suggesting that a similar mechanism might be involved in llamas
that ovulate spontaneously.
The pattern of plasma progesterone release after induction
of ovulation with an injection of a GnRH analog in this study
is similar to that previously reported in other studies in llamas.
Plasma progesterone concentration starts to increase on Day 4
and reaches maximum concentration at Day 8, and a decrease is
observed between Days 10 and 12 after induction of ovulation
(25, 26).
The observation that females treated with 1.6mg of estradiol-
17β achieved plasma progesterone concentration above 1 ng
ml−1 and the highest plasma progesterone concentration 1 day
later than animals treated with the GnRH analog could be in
relation to the time elapsed between treatment and the LH
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surge and therefore the moment of ovulation. Previous studies
in llamas (27, 28) and cows (29) have reported that LH peak
occurs ∼2 h after injection of a GnRH analog. In addition, it
has been shown in llamas that ovulation occurs around 29 h
after treatment (7). Although there are no reports demonstrating
the time elapsed between estradiol injection and LH surge in
camelids, it could be speculated that the LH peak might occur
between 12 and 18 h post injection, as previously reported in
other species [cows: (30, 31); ewes: (8)]. Even though the time
elapsed between treatment and ovulation was not evaluated in
the present study, it could be suggested that llamas treated with
estradiol-17β would have a retarded LH peak and consequently
ovulate some hours later than those treated with a GnRH analog
injection. Thereafter, it would determine a later development and
functionality of the CL.
In summary, the results of the present study demonstrate that
an injection of estradiol-17β is able to induce ovulation in llamas
and that the response depends on the dose used. Most of the
animals required the highest tested dose (1.6mg) to induce the
ovulatory process. Although the CL diameter in females induced
to ovulate with estradiol was similar to that in llamas induced
to ovulate with a GnRH analog, the rise in plasma progesterone
concentration above 1 ng ml−1 and the peak progesterone
concentration were attained 1 day later in the estradiol treated
females. This information enables a better understanding of the
ovulatory process in llamas, and the injection of estradiol-17β
could be considered as a tool to develop new strategies to control
ovarian activity in this species.
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